Bio-radiation dermatitis: the need of a new grading: in regard to Bernier et al: Ann Oncol 2011; 22(10): 2191–2200
Open Access
- 29 July 2013
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 24 (9) , 2463-2465
Abstract
The authors have declared no conflicts of interest.Keywords
This publication has 5 references indexed in Scilit:
- Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0Journal of the American Academy of Dermatology, 2012
- Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelinesAnnals of Oncology, 2011
- Mometasone Furoate Effect on Acute Skin Toxicity in Breast Cancer Patients Receiving Radiotherapy: A Phase III Double-Blind, Randomized Trial From the North Central Cancer Treatment Group N06C4International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study groupSupportive Care in Cancer, 2010
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalThe Lancet Oncology, 2010